Alphanate SD/HT

BIOLOGICAL2 trials

Sponsors

Grifols Biologicals, LLC

Conditions

Severe Hemophilia AVon Willebrand Disease

Phase 4

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

CompletedNCT00323856

Grifols Biologicals, LLCSevere Hemophilia A

Start: 2003-04-08End: 2018-12-14Updated: 2025-01-16

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients

Active, not recruitingNCT00555555

Grifols Biologicals, LLCVon Willebrand Disease

Start: 2007-09-30End: 2029-03-31Target: 15Updated: 2023-08-25